AAAAAA

   
Results: 1-18 |
Results: 18
Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors
Authors: Hendren, SK Hahn, SM Spitz, FR Bauer, TW Rubin, SC Zhu, T Glatstein, E Fraker, DL
Citation: Sk. Hendren et al., Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors, ANN SURG O, 8(1), 2001, pp. 65-71
Survival of BRCA1 negative ovarian cancer patients based on family history
Authors: Chu, CS Morgan, MA Randall, TC Bandera, CA Rubin, SC
Citation: Cs. Chu et al., Survival of BRCA1 negative ovarian cancer patients based on family history, GYNECOL ONC, 83(1), 2001, pp. 109-114
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
Authors: Woo, EY Chu, CS Goletz, TJ Schlienger, K Yeh, H Coukos, G Rubin, SC Kaiser, LR June, CH
Citation: Ey. Woo et al., Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer, CANCER RES, 61(12), 2001, pp. 4766-4772
Cervical cancer: Successes and failures
Authors: Rubin, SC
Citation: Sc. Rubin, Cervical cancer: Successes and failures, CA-A CANC J, 51(2), 2001, pp. 89-91
p53 mutations and microsatellite instability in ovarian cancer: Yin and Yang - Discussion
Authors: Rubin, SC Taylor, R",Buller
Citation: Sc. Rubin et Taylor, R",buller, p53 mutations and microsatellite instability in ovarian cancer: Yin and Yang - Discussion, AM J OBST G, 184(5), 2001, pp. 902-903
Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer
Authors: Coukos, G Makrigiannakis, A Kang, EH Rubin, SC Albelda, SM Molnar-Kimber, KL
Citation: G. Coukos et al., Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer, CLIN CANC R, 6(8), 2000, pp. 3342-3353
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy
Authors: Coukos, G Makrigiannakis, A Montas, S Kaiser, LR Toyozumi, T Benjamin, I Albelda, SM Rubin, SC Molnar-Kimber, KL
Citation: G. Coukos et al., Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy, CANC GENE T, 7(2), 2000, pp. 275-283
Management of intestinal obstruction in the patient with ovarian cancer
Authors: Randall, TC Rubin, SC
Citation: Tc. Randall et Sc. Rubin, Management of intestinal obstruction in the patient with ovarian cancer, ONCOLOGY-NY, 14(8), 2000, pp. 1159
Untitled
Authors: Rubin, SC
Citation: Sc. Rubin, Untitled, GYNECOL ONC, 78(3), 2000, pp. 395-395
Prolonged remission of recurrent, metastatic placental site trophoblastic tumor after chemotherapy
Authors: Randall, TC Coukos, G Wheeler, JE Rubin, SC
Citation: Tc. Randall et al., Prolonged remission of recurrent, metastatic placental site trophoblastic tumor after chemotherapy, GYNECOL ONC, 76(1), 2000, pp. 115-117
Surgical management of ovarian cancer
Authors: Randall, TC Rubin, SC
Citation: Tc. Randall et Sc. Rubin, Surgical management of ovarian cancer, SEM SURG ON, 17(3), 1999, pp. 173-180
Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer
Authors: Coukos, G Makrigiannakis, A Kang, EH Caparelli, D Benjamin, I Kaiser, LR Rubin, SC Albelda, SM Molnar-Kimber, KL
Citation: G. Coukos et al., Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer, CLIN CANC R, 5(6), 1999, pp. 1523-1537
Intestinal obstruction in advanced ovarian cancer: What does the patient want?
Authors: Rubin, SC
Citation: Sc. Rubin, Intestinal obstruction in advanced ovarian cancer: What does the patient want?, GYNECOL ONC, 75(3), 1999, pp. 311-312
Endometrial carcinoma associated with pregnancy: A report of three cases and review of the literature
Authors: Vaccarello, L Apte, SM Copeland, LJ Boutselis, JG Rubin, SC
Citation: L. Vaccarello et al., Endometrial carcinoma associated with pregnancy: A report of three cases and review of the literature, GYNECOL ONC, 74(1), 1999, pp. 118-122
Occult bilateral involvement in Stage I epithelial ovarian cancer
Authors: Benjamin, I Morgan, MA Rubin, SC
Citation: I. Benjamin et al., Occult bilateral involvement in Stage I epithelial ovarian cancer, GYNECOL ONC, 72(3), 1999, pp. 288-291
Ten-year follow-up of ovarian cancer patients after second-look laparotomywith negative findings
Authors: Rubin, SC Randall, TC
Citation: Sc. Rubin et Tc. Randall, Ten-year follow-up of ovarian cancer patients after second-look laparotomywith negative findings, OBSTET GYN, 93(1), 1999, pp. 21-24
Complete hydatidiform mole - A disease with a changing profile
Authors: Coukos, G Makrigiannakis, A Chung, J Randall, TC Rubin, SC Benjamin, I
Citation: G. Coukos et al., Complete hydatidiform mole - A disease with a changing profile, J REPRO MED, 44(8), 1999, pp. 698-704
Allelotype analysis of uterine leiomyoma: Localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q
Authors: van der Heijden, O Chiu, HC Park, TC Takahashi, H LiVolsi, VA Risinger, JI Barrett, JC Berchuck, A Evans, AC Behbakht, K Menzin, AW Liu, PC Benjamin, I Morgan, MA King, SA Rubin, SC Boyd, J
Citation: O. Van Der Heijden et al., Allelotype analysis of uterine leiomyoma: Localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q, MOL CARCINO, 23(4), 1998, pp. 243-247
Risultati: 1-18 |